Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Janus Henderson Group PLC

Janus Henderson Group PLC trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 663,902 shares of the medical equipment provider’s stock after selling 26,037 shares during the quarter. Janus Henderson Group PLC owned about 0.19% of Intuitive Surgical worth $346,535,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of ISRG. Atala Financial Inc purchased a new position in shares of Intuitive Surgical in the fourth quarter worth about $25,000. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter worth about $26,000. Parvin Asset Management LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter worth about $26,000. BankPlus Trust Department purchased a new position in shares of Intuitive Surgical in the fourth quarter worth about $28,000. Finally, Hurley Capital LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter worth about $28,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, EVP Myriam Curet sold 408 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the transaction, the executive vice president now owns 353 shares in the company, valued at approximately $208,181.75. This trade represents a 53.61% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Jamie Samath sold 188 shares of Intuitive Surgical stock in a transaction on Friday, February 28th. The shares were sold at an average price of $566.94, for a total value of $106,584.72. Following the completion of the sale, the chief financial officer now owns 7,162 shares in the company, valued at $4,060,424.28. This represents a 2.56% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 33,044 shares of company stock worth $17,070,433. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $536.55 on Monday. The company has a market cap of $192.31 billion, a PE ratio of 83.71, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70. The stock’s 50 day simple moving average is $500.93 and its 200-day simple moving average is $535.03. Intuitive Surgical, Inc. has a 1-year low of $379.67 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter last year, the business posted $1.50 earnings per share. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms recently commented on ISRG. UBS Group raised their target price on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a report on Monday, January 27th. Raymond James raised their target price on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Citigroup raised their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Erste Group Bank lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 17th. Finally, Evercore ISI dropped their target price on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating on the stock in a report on Wednesday, April 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $598.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.